In hindsight sure Sewell would have posted his original post either not mentioning the reference in the first place (for obvious reasons) or clarifying what was said, agree it is not ideal to leave people ‘hanging’.
Credit to him though for clarifying in spite of the ‘expected’ disparaging return comments that would be in the wings.
With your first para: I do think it should be in your bear thesis notes, some way off is relevant; further funding, more dilution and the usual trading opportunities for entities to ‘play’ their money making agenda.
In regard to distasteful conduct on HC you get a large measure of it from those posters that are bullish, (any stock), and usually rewarded with a thumb up.
Would you think that ‘many’ of us here are actually only here to have their confirmation bias reinforced, that any discussion that is bearish is not tolerated.
With upcoming positive announcements this sp will need to finally reflect its intrinsic value, when?, if not in the next six months it should be questioned why?
- Forums
- ASX - By Stock
- AVR
- Cardiology
AVR
anteris technologies global corp.
Add to My Watchlist
6.09%
!
$6.27

Cardiology, page-29
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M |
Open | High | Low | Value | Volume |
$5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | $6.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.27 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 6.120 |
1 | 2000 | 6.100 |
1 | 1250 | 5.950 |
1 | 857 | 5.830 |
1 | 900 | 5.780 |
Price($) | Vol. | No. |
---|---|---|
6.300 | 463 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
6.550 | 1092 | 1 |
6.600 | 320 | 1 |
Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online